| Name | Title | Contact Details |
|---|
Fair. Rude. But fair. Lets take the second question first. In competitive cycling, Domestiques are riders who lead the pack, breaking headwinds to make the journey easier for the team. And its the love of doing the hard, foundational, gritty and unglamorous work that informs everything we do. Now, to your first question. Domestique is a management consultant company that helps businesses scale through go-to-market operations (aka Revenue Operations or RevOps). Not sure what that answer means? No sweat. We, in the next paragraph. will make it as long-winded as possible. We are Rhys Williams and Alex Biale, co-founders of Domestique. We have a combined 25+ years in go-to-market operations experience, translating CEO questions like "lets move up market" and "lets expand internationally" into best-in-class operations. Our expertise informed the development of a GTM operational framework that we use to help companies create, accelerate and optimize their revenue engines. And our understanding of building, scaling, funding and preparing your company for exit is what sets our expertise apart. Our mission? Empower your business to unlock growth levers to do great things. (What are growth levers? Theyre things like Capacity Planning, Lead Scoring, Customer Segmentation, Comp Strategy, and other terms that sound like things we just made up). Growing a business is hard and too often companies fail because they lack the preparation, agility and connective tissue to get through the hard part. We help by though strategic and technical services to align your business strategy with your go-to-market playbook. Because visualizing your goals, your outcomes and life-changing moments—thats where you come in. Getting you from mile marker to mile marker—thats where we come in. After all, thats our role as your Domestique—Your accelerator. Your guide. Your teammate.
Continental Generals mission is to assist our customers with managing the financial risks and challenges that come as they age. Our skills, resources, and infrastructure allow us to help them with insulating and enhancing retirement income and maneuvering caregiving options. Thus allowing us to responsibly be a part of the solution rather than the problem. Our team of long-term care industry experts, with headquarters in Austin, Texas, strives to build value through superior operating results. As we manage our current portfolio of business, we continue to pursue growth opportunities for expansion and economies of scale through strategic acquisitions, mergers, and reinsurance opportunities. Our family of insurance companies and strategic partners provide administrative services to approximately 125,000 Long-Term Care, Life, Annuity and Supplemental Health customers. We are dedicated to upholding the commitments we have made to provide excellent service to all our customers and serve the needs of our claimants and their families during difficult times.
Berkowitz Pollack Brant is one of the largest public accounting firms in the Southeastern US. Our team of accounting and consulting professionals work with affiliate firms Provenance Wealth Advisors, BayBridge Capital Advisors and BayBridge Real Estate Capital to bring clients a comprehensive approach to income, estate, financial and business planning. Our main areas of focus include domestic and international tax, audit and assurance services, business advisory services, estate and corporate planning, forensic accounting, litigation support and business valuation. Our clients are entrepreneurs, executives, and privately held and publicly traded companies in the United States and Latin America. We have been recognized by both Accounting Today and INSIDE Public Accounting as one of the top 60 firms in the U.S. and INSIDE Public Accounting named us one of the "Best of the Best" CPA firms in America 19 times. For more information, visit www.bpbcpa.com, www.provwealth.com, www.baybridgecapitaladvisors.com or www.baybridgerec.com.
I am Eleanor Allen - a proven CEO turned business consultant and coach. I founded Catapult For Change to save you time by offering you surefire success due to my deep experience in business transformations, turnarounds, and growth strategies. Ill guide you to excel in the C-Suite, fostering a personal leadership exploration that uplifts both you and your organization. The inception of Catapult For Change stemmed from my passion to empower executives in unlocking their full potential. I firmly believe in the inherent greatness within each individual; however, obstacles occasionally hinder our progress. Our mission is to guide individuals and teams in overcoming these hurdles through a comprehensive approach to problem-solving and personal growth. This extends to our dedicated support for CEOs and C-Suite leaders, fostering the development of skills and talents that enable them to excel in their roles with both grace and joy. My personal purpose is to enhance the quality of life for both people and the planet, and Catapult For Change serves as my conduit to do this. Operating as a Public Benefit Corporation (PBC), Catapult For Change distinguishes itself by not only functioning similarly to an S Corp or an LLC but also by incorporating a public benefit element. Based in Colorado, Catapult For Change aligns with the PBC criteria by contributing to the philanthropic endeavors of Water For People - an organization I formerly led. Water For People operates globally across nine countries in Latin America, Asia, and Africa, addressing the urgent global water crisis and empowering communities with sustainable access to clean water and sanitation services, with the commitment of Everyone, Forever. Catapult For Change pledges annual donations to support Water For Peoples mission. As a PBC, our commitment to this cause is transparently showcased in our mandatory annual impact report, a requirement for all PBCs filed in the State of Colorado.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.